Effect of physostigmine and neostigmine on the glycogen stores in the heart and in the adrenals.
D000311:Adrenal Glands / Q000187:drug effects / Q000378:metabolism; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D004298:Dopamine / Q000494:pharmacology; D004336:Drug Antagonism; D006003:Glycogen / Q000096:biosynthesis / Q000378:metabolism*; D006321:Heart / Q000187:drug effects; D006325:Heart Atria / Q000187:drug effects / Q000378:metabolism; D066298:In Vitro Techniques; D008297:Male; D009206:Myocardium / Q000378:metabolism*; D009388:Neostigmine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D010636:Phenols / Q000494:pharmacology; D010830:Physostigmine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D012459:Salicylates / Q000494:pharmacology; D013464:Sulfuric Acids / Q000494:pharmacology
D010636:Phenols; D012459:Salicylates; D013464:Sulfuric Acids; D009388:Neostigmine; D001285:Atropine; D006003:Glycogen; D010830:Physostigmine; D011433:Propranolol; D004298:Dopamine